Tounjian Advisory Partners LLC Invests $897,000 in Unum Group (NYSE:UNM)

Tounjian Advisory Partners LLC purchased a new position in Unum Group (NYSE:UNM - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 11,018 shares of the financial services provider's stock, valued at approximately $897,000.

A number of other hedge funds have also recently modified their holdings of the company. Brighton Jones LLC bought a new position in shares of Unum Group during the fourth quarter valued at approximately $247,000. Stratos Wealth Partners LTD. bought a new position in Unum Group in the 4th quarter worth $216,000. Bleakley Financial Group LLC increased its position in shares of Unum Group by 3.5% during the fourth quarter. Bleakley Financial Group LLC now owns 7,044 shares of the financial services provider's stock valued at $514,000 after buying an additional 235 shares during the period. Savant Capital LLC boosted its position in shares of Unum Group by 1.0% during the fourth quarter. Savant Capital LLC now owns 46,344 shares of the financial services provider's stock valued at $3,385,000 after purchasing an additional 476 shares in the last quarter. Finally, Summit Trail Advisors LLC boosted its position in shares of Unum Group by 47.3% during the fourth quarter. Summit Trail Advisors LLC now owns 8,094 shares of the financial services provider's stock valued at $591,000 after purchasing an additional 2,600 shares in the last quarter. Hedge funds and other institutional investors own 86.57% of the company's stock.

Unum Group Stock Down 2.0%

UNM stock traded down $1.64 during midday trading on Tuesday, hitting $78.81. The company's stock had a trading volume of 1,132,490 shares, compared to its average volume of 1,316,131. The firm's 50-day moving average is $78.54 and its 200-day moving average is $77.03. The company has a current ratio of 0.29, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32. Unum Group has a 12 month low of $48.38 and a 12 month high of $84.48. The company has a market cap of $13.74 billion, a PE ratio of 8.32, a P/E/G ratio of 1.14 and a beta of 0.43.

Unum Group (NYSE:UNM - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The financial services provider reported $2.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.19 by ($0.15). Unum Group had a net margin of 13.81% and a return on equity of 14.91%. The business had revenue of $3.09 billion for the quarter, compared to the consensus estimate of $3.34 billion. During the same period in the previous year, the company earned $2.12 earnings per share. The company's revenue for the quarter was down 3.4% compared to the same quarter last year. On average, equities research analysts forecast that Unum Group will post 9.14 earnings per share for the current fiscal year.

Unum Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 16th. Stockholders of record on Friday, April 25th were issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date was Friday, April 25th. Unum Group's payout ratio is presently 19.79%.

Unum Group declared that its board has initiated a share repurchase program on Tuesday, February 18th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to buy up to 7.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

UNM has been the subject of several recent research reports. Piper Sandler raised their price objective on Unum Group from $87.00 to $92.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods lowered their price target on shares of Unum Group from $103.00 to $102.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Wells Fargo & Company boosted their price objective on shares of Unum Group from $95.00 to $97.00 and gave the stock an "overweight" rating in a research note on Thursday, May 1st. Morgan Stanley raised their target price on shares of Unum Group from $76.00 to $83.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Unum Group from $81.00 to $87.00 and gave the company a "neutral" rating in a report on Wednesday, April 2nd. Five research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $88.29.

Insider Activity

In other Unum Group news, EVP Elizabeth Claire Ahmed sold 10,000 shares of the firm's stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $80.00, for a total value of $800,000.00. Following the transaction, the executive vice president now directly owns 51,170 shares of the company's stock, valued at approximately $4,093,600. This trade represents a 16.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.92% of the stock is owned by corporate insiders.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.